av/roivant-sciences--big.svg

COM:ROIVANT

Roivant Sciences Ltd.

  • Stock

Last Close

12.02

30/08 20:00

Market Cap

8.31B

Beta: -

Volume Today

4.92M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
-749.37M
-
-519.39M
30.69%
-900.23M
73.32%
-924.12M
2.65%
-1.12B
20.71%
4.23B
479.32%
depreciation and amortization
5.93M
-
18.86M
217.89%
22.04M
16.86%
deferred income tax
-5.93M
-
-4.36M
26.52%
stock based compensation
58.86M
-
122.57M
108.24%
84.96M
30.69%
564.96M
564.98%
217.78M
61.45%
199.63M
8.34%
change in working capital
49.67M
-
15.30M
69.21%
71.94M
370.31%
15.72M
78.15%
6.34M
59.63%
19.04M
200%
accounts receivables
inventory
accounts payables
4.54M
-
6.60M
45.43%
3.75M
43.13%
15.40M
310.53%
4.36M
71.70%
22.68M
420.39%
other working capital
45.14M
-
8.70M
80.73%
68.19M
683.93%
316K
99.54%
1.99M
528.48%
-3.65M
283.74%
other non cash items
-383.40M
-
-380.31M
0.81%
191.20M
150.28%
-334.29M
274.84%
33.45M
110.01%
96.04M
187.14%
net cash provided by operating activities
-1.02B
-
-761.83M
25.62%
-552.14M
27.52%
-677.73M
22.75%
-843.39M
24.44%
-765.27M
9.26%
investments in property plant and equipment
-11.40M
-
-4.92M
56.86%
-5.81M
18.10%
-17.44M
200.31%
-12.69M
27.22%
-1.38M
89.11%
acquisitions net
-2.60M
-
1.77B
68,268.18%
-39K
-
107.86M
276,651.28%
-36.98M
134.29%
purchases of investments
-43.61M
-
-68.38M
56.78%
-28.25M
58.68%
39K
100.14%
sales maturities of investments
46.21M
-
16.44M
64.42%
320.17M
-
5.23B
-
other investing activites
-46.21M
-
-20.05M
56.62%
2.35M
111.74%
561K
76.17%
-139.43M
24,954.55%
5.24B
3,859.48%
net cash used for investing activites
-57.61M
-
1.69B
3,041.94%
-31.70M
101.87%
303.30M
1,056.71%
-44.27M
114.60%
5.20B
11,854.55%
debt repayment
-9.71M
-
-32.06M
230.31%
-21.59M
-
-30.14M
39.62%
-30.70M
1.86%
common stock issued
598.86M
-
1.35B
126.13%
455.76M
66.35%
313.42M
31.23%
379.71M
21.15%
438.56M
15.50%
common stock repurchased
-7.38M
-
-1.19B
16,014.78%
-113K
99.99%
316K
-
951K
200.95%
dividends paid
-162.71M
-
other financing activites
185.24M
-
83.48M
54.93%
621K
99.26%
14.96M
2,308.70%
312.30M
1,987.81%
-43.76M
114.01%
net cash used provided by financing activities
767.02M
-
217.16M
71.69%
456.26M
110.10%
306.79M
32.76%
499.46M
62.80%
419.36M
16.04%
effect of forex changes on cash
1.43B
-
6.28M
-
616K
90.19%
net change in cash
1.12B
-
1.34B
19.37%
-127.58M
109.55%
-67.64M
46.98%
-381.92M
464.62%
4.86B
1,372.09%
cash at beginning of period
-269.58M
-
849.55M
415.14%
2.27B
167.11%
2.14B
5.62%
2.07B
3.16%
1.69B
18.41%
cash at end of period
849.55M
-
2.19B
157.25%
2.14B
2.00%
2.07B
3.16%
1.69B
18.41%
6.55B
287.12%
operating cash flow
-1.02B
-
-761.83M
25.62%
-552.14M
27.52%
-677.73M
22.75%
-843.39M
24.44%
-765.27M
9.26%
capital expenditure
-11.40M
-
-4.92M
56.86%
-5.81M
18.10%
-17.44M
200.31%
-12.69M
27.22%
-1.38M
89.11%
free cash flow
-1.04B
-
-766.75M
25.96%
-557.94M
27.23%
-695.16M
24.59%
-856.08M
23.15%
-766.65M
10.45%

All numbers in (except ratios and percentages)